Cargando…
Metabolic syndrome-related prognostic index: Predicting biochemical recurrence and differentiating between cold and hot tumors in prostate cancer
BACKGROUND: The prostate, as an endocrine and reproductive organ, undergoes complex hormonal and metabolic changes. Recent studies have shown a potential relationship between metabolic syndrome and the progression and recurrence of prostate cancer (PCa). This study aimed to construct a metabolic syn...
Autores principales: | Ren, Congzhe, Wang, Qihua, Wang, Shangren, Zhou, Hang, Xu, Mingming, Li, Hu, Li, Yuezheng, Chen, Xiangyu, Liu, Xiaoqiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10080042/ https://www.ncbi.nlm.nih.gov/pubmed/37033267 http://dx.doi.org/10.3389/fendo.2023.1148117 |
Ejemplares similares
-
Comparative efficacy of second-generation androgen receptor inhibitors for treating prostate cancer: A systematic review and network meta-analysis
por: Chen, Xiangyu, et al.
Publicado: (2023) -
Identification of bicalutamide resistance-related genes and prognosis prediction in patients with prostate cancer
por: Li, Yuezheng, et al.
Publicado: (2023) -
Identifying hub genes and common biological pathways between COVID-19 and benign prostatic hyperplasia by machine learning algorithms
por: Zhou, Hang, et al.
Publicado: (2023) -
Comparative efficacy of olaparib in combination with or without novel antiandrogens for treating metastatic castration-resistant prostate cancer
por: Chen, Xiangyu, et al.
Publicado: (2023) -
Association of serum 25-hydroxyvitamin D with urinary incontinence in elderly men: evidence based on NHANES 2007-2014
por: Liu, Li, et al.
Publicado: (2023)